scholarly journals Influenza B Virus-associated Pneumonia in Pediatric Patients: Clinical Features, Laboratory Data, and Chest X-ray Findings

2014 ◽  
Vol 55 (1) ◽  
pp. 58-64 ◽  
Author(s):  
Chi-Yu Liu ◽  
Jiaan-Der Wang ◽  
Jen-Ta Yu ◽  
Li-Ching Wang ◽  
Ming-Chih Lin ◽  
...  
Vaccine ◽  
2019 ◽  
Vol 37 (43) ◽  
pp. 6550-6557 ◽  
Author(s):  
M. Hönemann ◽  
D. Martin ◽  
C. Pietsch ◽  
M. Maier ◽  
S. Bergs ◽  
...  

PEDIATRICS ◽  
1991 ◽  
Vol 88 (5) ◽  
pp. 1031-1036
Author(s):  
Roland A. Levandowski ◽  
Helen L. Regnery ◽  
Eldridge Staton ◽  
B. Gail Burgess ◽  
Michael S. Williams ◽  
...  

The cocirculation in several parts of the world of influenza viruses B/Yamagata/16/88 and B/Victoria/2/87, which are genetically and antigenically divergent, has prompted the question of whether immunization with one viral antigen is sufficient for protection against both strains. Twenty-three high-risk infants and young children were immunized with a commercial trivalent influenza vaccine containing the antigens of influenza virus B/Yamagata/16/88. When antibodies against influenza viruses B/Yamagata/16/88 and B/Victoria/2/87 were determined, increases developed uniformly to both in the sera of primed children previously exposed to influenza virus B/Victoria/2/87 by immunization or infection. Antibodies against B/Yamagata/16/88 developed in the sera of unprimed children with titers similar to those of the primed children. However, antibodies to B/ Victoria/2/87 were not detected in the sera of the unprimed children. These data suggest that children with out appropriate immunologic priming may not be protected against an infection with a B/Victoria/2/87 strain after vaccination with a B/Yamagata/16/88 strain. Immunization with more than one influenza B virus strain may be desirable in some high-risk pediatric patients if divergent influenza B viruses circulate.


2020 ◽  
Vol 7 (Supplement_1) ◽  
pp. S762-S763
Author(s):  
Angel L Perez-Caro ◽  
Frances Quiñones-Del Toro ◽  
Marilyn García-Burgos ◽  
Vanessa Rivera-Amill ◽  
Luisa I Alvarado-Domenech

Abstract Background Influenza is one of the most common viral respiratory diseases in the United States with 9–45 million cases per year. In Puerto Rico, more than 18,000 cases of influenza were reported during the 2019/20 season. The Sentinel Enhanced Dengue Surveillance System (SEDSS) conducts acute febrile illness surveillance for inpatient and outpatients at a southern Puerto Rico tertiary care hospital. Methods We performed a retrospective analysis of disease severity among laboratory-confirmed influenza cases enrolled in SEDSS. Cases with complications such as pneumonia or bronchitis evidenced by chest x-ray or clinical diagnosis were classified as severe. Results Between January 2016 and December 2019, there were 2,835 laboratory-confirmed influenza cases. More than half (1,662, 59%) were aged 0–20 years, 51% (n=1,447)were female, and 4% (n=124)required hospital admission. Among all influenza cases, influenza A virus was most common (n = 1,963, 69%) followed by influenza B virus (n = 872, 31%). Odds of having influenza A were higher among adults (OR=1.62; 95% CI:1.38-1.92). Chronic disease history among influenza cases included: asthma (n= 507, 18%), hypertension (n = 337, 12%), hypercholesterolemia (n = 157, 6%), coronary heart disease (n = 79, 3%), immunodeficiency (n = 11, 1%), and kidney disease (n = 10, 1%). Overall, 61(2%) influenza cases developed complications, 21 developed pneumonia of which 85% had chest x-ray performed. One-third of influenza cases with pneumonia or bronchitis had preexisting conditions like asthma (33%) and hypertension (34%). Seventy five percent of Influenza A cases with asthma developed bronchitis or pneumonia. The odds of having severe Influenza were higher among patients with underlying hypertension compared to those without hypertension (OR= 3.8; 95% CI:2.0–7.1). Moreover, influenza cases with asthma had a higher odd of developing pneumonia or bronchitis as compared to those without asthma (OR=2.3; 95% CI: 1.3–4.0). While asthma is a recognized risk factor for influenza complications, isolated hypertension is not. Conclusion Identifying people at risk for influenza complications provides a guide for clinicians and public health officials to implement preventive measures and improve clinical outcomes. Disclosures All Authors: No reported disclosures


1988 ◽  
Vol 263 (13) ◽  
pp. 6421-6423
Author(s):  
P J Bossart ◽  
Y S Babu ◽  
W J Cook ◽  
G M Air ◽  
W G Laver

1992 ◽  
Vol 11 (2) ◽  
pp. 117-121 ◽  
Author(s):  
JANE F. TROENDLE ◽  
GAIL J. DEMMLER ◽  
W. PAUL GLEZEN ◽  
MILTON FINEGOLD ◽  
MICHAEL J. ROMANO

PLoS ONE ◽  
2017 ◽  
Vol 12 (10) ◽  
pp. e0185893 ◽  
Author(s):  
Antonio Piralla ◽  
Giovanna Lunghi ◽  
Luca Ruggiero ◽  
Alessia Girello ◽  
Sonia Bianchini ◽  
...  

2013 ◽  
Vol 19 (3) ◽  
pp. 511-512 ◽  
Author(s):  
Rogier Bodewes ◽  
Danny Morick ◽  
Gerrie de Mutsert ◽  
Nynke Osinga ◽  
Theo Bestebroer ◽  
...  

PLoS ONE ◽  
2015 ◽  
Vol 10 (1) ◽  
pp. e0116302 ◽  
Author(s):  
Nipaporn Tewawong ◽  
Kamol Suwannakarn ◽  
Slinporn Prachayangprecha ◽  
Sumeth Korkong ◽  
Preeyaporn Vichiwattana ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document